These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 4990080)
1. [Present position of the toxicology of drugs]. Frohberg H Munch Med Wochenschr; 1970 Aug; 112(35):1532-43. PubMed ID: 4990080 [No Abstract] [Full Text] [Related]
2. Teratogenic drug screening. Present procedures and requirements. Tuchmann-Duplessis H Teratology; 1972 Jun; 5(3):271-85. PubMed ID: 5067718 [No Abstract] [Full Text] [Related]
3. [Toxicology of the antileprosy drug 3-(para-chloranilino)-10-(para-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazine (G 30 320). Acute and subchronic toxicity, reproduction toxicology]. Stenger EG; Aeppli L; Peheim E; Thomann PE Arzneimittelforschung; 1970 Jun; 20(6):794-9. PubMed ID: 4989740 [No Abstract] [Full Text] [Related]
4. [Current status of the problem of testing drugs for carcinogenicity]. Shashkina LF; Ivanova VM; Liubimov BI Farmakol Toksikol; 1985; 48(3):107-13. PubMed ID: 3896842 [No Abstract] [Full Text] [Related]
5. [Preclinical investigation and testing of nontoxicity of drugs in the pharmaceutrial industry]. Tripod J Schweiz Med Wochenschr; 1968 Aug; 98(31):1152-8. PubMed ID: 4236567 [No Abstract] [Full Text] [Related]
6. [Fetal damage by drugs in animal experiments (prenatal toxicology-a new branch of experimental research)]. von Kreybig T Hippokrates; 1969 Mar; 40(6):201-9. PubMed ID: 5802153 [No Abstract] [Full Text] [Related]
7. Problems associated with the screening of drugs for possible teratogenic activity. Palmer AK Exp Embryol Teratol; 1974; 1(0):16-33. PubMed ID: 4464051 [No Abstract] [Full Text] [Related]
8. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480 [TBL] [Abstract][Full Text] [Related]
9. Brain to bottle time. Burt RA Proc R Soc Med; 1974 Jun; 67(7):584-6. PubMed ID: 4211842 [No Abstract] [Full Text] [Related]
10. Malformations caused by drugs in pregnancy. Lenz W Am J Dis Child; 1966 Aug; 112(2):99-106. PubMed ID: 5330368 [No Abstract] [Full Text] [Related]
11. Some remaining problems in the reproductive toxicity testing of drugs. Berry CL; Barlow S Br Med Bull; 1976 Jan; 32(1):34-8. PubMed ID: 816408 [No Abstract] [Full Text] [Related]
12. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council. Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111 [No Abstract] [Full Text] [Related]
13. Reproductive toxicity testing for pharmaceuticals under ICH. Barrow PC Reprod Toxicol; 2009 Sep; 28(2):172-9. PubMed ID: 19631153 [TBL] [Abstract][Full Text] [Related]
19. [Species differences in the metabolism of drugs]. Sjöqvist F Nord Med; 1967 Oct; 78(42):1364. PubMed ID: 5590749 [No Abstract] [Full Text] [Related]
20. Toxicity of ebrotidine on reproduction. Toxicity on fertility and general reproductive performance, embryo-fetal toxicity and peri- and postnatal toxicity. Romero A; Grau MT; Villamayor F; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):504-10. PubMed ID: 9205753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]